These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 38730371

  • 1. Potential impact of blood cholesterol guidelines on statin treatment in the U.S. population using interrupted time series analysis.
    Yew PY, Loth M, Adam TJ, Wolfson J, Liang Y, Tonellato PJ, Chi CL.
    BMC Cardiovasc Disord; 2024 May 10; 24(1):245. PubMed ID: 38730371
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
    Hamoui O, Omar MI, Raal FJ, Rashed W, Kane A, Alami M, Abreu P, Mashhoud W, Alsheikh-Ali AA.
    BMC Cardiovasc Disord; 2019 Mar 15; 19(1):61. PubMed ID: 30876390
    [Abstract] [Full Text] [Related]

  • 5. Trends in Statin Use 2009-2015 in a Large Integrated Health System: Pre- and Post-2013 ACC/AHA Guideline on Treatment of Blood Cholesterol.
    Harrison TN, Scott RD, Cheetham TC, Chang SC, Hsu JY, Wei R, Ling Grant DS, Boklage SH, Romo-LeTourneau V, Reynolds K.
    Cardiovasc Drugs Ther; 2018 Aug 15; 32(4):397-404. PubMed ID: 30062465
    [Abstract] [Full Text] [Related]

  • 6. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
    Bellows BK, Olsen CJ, Voelker J, Wander C.
    J Manag Care Spec Pharm; 2016 Aug 15; 22(8):892-900. PubMed ID: 27459651
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.
    Schonmann Y, Bleich O, Matalon A, Yeshua H.
    Eur J Prev Cardiol; 2018 May 15; 25(8):870-880. PubMed ID: 29517367
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J, Rajalingam T, Fossella J, Zhou H, Eisenberg N, Roche-Nagle G.
    Ann Vasc Surg; 2020 Nov 15; 69():197-205. PubMed ID: 32554202
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
    März W, Dippel FW, Theobald K, Gorcyca K, Iorga ŞR, Ansell D.
    Atherosclerosis; 2018 Jan 15; 268():99-107. PubMed ID: 29197254
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations.
    Zupec JF, Marrs JC, Saseen JJ.
    Ann Pharmacother; 2016 Jan 15; 50(1):17-21. PubMed ID: 26416950
    [Abstract] [Full Text] [Related]

  • 18. Ethnic differences in guideline-indicated statin initiation for people with type 2 diabetes in UK primary care, 2006-2019: A cohort study.
    Eastwood SV, Mathur R, Sattar N, Smeeth L, Bhaskaran K, Chaturvedi N.
    PLoS Med; 2021 Jun 15; 18(6):e1003672. PubMed ID: 34185782
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.
    Lowenstern A, Li S, Navar AM, Virani S, Lee LV, Louie MJ, Peterson ED, Wang TY.
    Am Heart J; 2018 Jun 15; 200():118-124. PubMed ID: 29898839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.